無引線起搏系統的全球市場:產業分析，規模，佔有率，成長，趨勢，預測(2024年～2031年)

本報告提供全球無引線起搏系統市場相關調查，提供應用各類型，各終端用戶，各地區趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 市場簡介

第3章 無引線起搏系統市場觀點

• 全球市場動態
• 宏觀經濟要素
• 機會分析

第4章 北美的無引線起搏系統市場分析與預測

第5章 南美的無引線起搏系統市場分析與預測

第6章 歐洲的無引線起搏系統市場分析與預測

第7章 亞太地區的無引線起搏系統市場分析與預測

第8章 中東·非洲的無引線起搏系統市場分析與預測

第9章 競爭情形

• 競爭儀表板
• 市場佔有率分析(2024年)
• 企業簡介(詳細內容- 概要，財務，策略，最近的趨勢)
• 主要企業
  • Abbott Laboratories
  • Medtronic Plc

第10章 全球無引線起搏系統市場分析與預測:各地區

• 簡介
• 市場規模分析:各地區
• 市場魅力分析:各地區

第11章 全球無引線起搏系統市場分析與預測:應用各類型

第12章 全球無引線起搏系統市場分析與預測:各終端用戶

第13章 全球無引線起搏系統市場分析與預測

第14章 所使用的假設和縮寫

第15章 調查手法

Persistence Market Research has recently released a comprehensive report on the global Leadless Pacing Systems Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

• Leadless Pacing Systems Market Size (2024): US$ 53.5 Mn
• Projected Market Growth Value (2031F): 102.4 Mn
• Global Market Growth Rate (CAGR 2024 to 2031): 9.7%

Leadless Pacing Systems Market - Report Scope:

Leadless pacing systems represent a significant innovation in the cardiac pacemaker industry, offering a less invasive alternative to traditional pacemakers. These systems eliminate the need for leads, reducing complications such as lead and pacemaker pocket issues. While limited to single-chamber ventricular pacing, leadless devices are proving to be effective for conditions like permanent atrial fibrillation, sinus node dysfunction, and atrioventricular block. The devices are implanted through a vein near the thigh, and retrieval is possible without complications, as confirmed by clinical studies. High implant success rates have been recorded in various trials, including St. Jude's Nanostim with a 97% success rate.

Market Growth Drivers:

The growth of the leadless pacing systems market is driven by several factors, including a rise in eligible patients, better reimbursement scenarios, increased disposable income, and growing preference for advanced technologies. Additionally, the aging population, higher rates of cardiovascular diseases, and expanding medical insurance are further propelling market expansion. The technology's benefits, such as its less invasive nature, long battery life, and the ability to provide relief from frequent pacing, are key factors supporting the market's growth.

Market Restraints:

Despite the positive growth outlook, the leadless pacing systems market faces certain challenges. Strict regulatory approvals, high product costs, and a limited number of operators with hands-on experience restrict market expansion. Battery depletion issues also pose a challenge to the widespread adoption of these devices. Furthermore, there is a need for professional education and training to increase the number of qualified professionals capable of performing these procedures.

Market Opportunities:

There are significant opportunities for growth in the leadless pacing systems market, particularly through advancements in dual-chamber and multi-chamber pacing systems. Companies have the potential to enhance product penetration by offering better training programs for medical professionals and expanding their distribution networks. Additionally, increasing awareness and improving healthcare infrastructure in emerging markets present growth opportunities for manufacturers.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the leadless pacing systems market?
• Which regions are witnessing the highest adoption of leadless pacing systems?
• How do technological advancements influence the competitive landscape of the market?
• Who are the leading players in the leadless pacing systems market, and what strategies are they employing to maintain market dominance?
• What are the emerging trends and future prospects in the global leadless pacing systems market?

Competitive Intelligence and Business Strategy:

Leading companies in the global leadless pacing systems market, including St. Jude's Medical (now Abbott) and Medtronic plc, are focusing on product innovation, strategic acquisitions, and regulatory approvals to stay competitive. These companies are investing in R&D to enhance the performance of leadless pacing devices and expand their product offerings. Collaboration with healthcare providers and improving professional training are key to expanding their market reach. As the market evolves, companies are focusing on technological advancements such as multi-chamber pacing systems to differentiate their products and offer additional value to patients.

Key Companies Profiled:

• Abbott Laboratories (St. Jude Medical)
• Medtronic plc
• Others

Leadless Pacing Systems Market Segmentation:

By Application:

• Atrial Fibrillation
• Sinus Node Dysfunction
• Atrioventricular Block
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Market Overview
• 1.2. Market Analysis
• 1.3. PMR Analysis and Recommendations
• 1.4. Wheel of Fortune

2. Market Introduction

• 2.1. Market Definition
• 2.2. Market Taxonomy
• 2.3. Leadless Pacing System Advantages
• 2.4. Approvals Road Map

3. Leadless Pacing System Market View Point

• 3.1. Global Market Dynamics
  • 3.1.1. Drivers
  • 3.1.2. Restraints
  • 3.1.3. Trends
• 3.2. Macro-Economic Factors
• 3.3. Opportunity Analysis

4. North America Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 4.1. Introduction
• 4.2. Pricing Analysis
• 4.3. Market Volume Analysis
• 4.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 4.4.1. U.S.
  • 4.4.2. Canada
• 4.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 4.5.1. Atrial Fibrillation
  • 4.5.2. Sinus Node Dysfunction
  • 4.5.3. Atrioventricular Block
  • 4.5.4. Others
• 4.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 4.6.1. Hospitals
  • 4.6.2. Ambulatory surgical centers
• 4.7. Market Attractiveness Analysis
  • 4.7.1. By Application Type
  • 4.7.2. By End user
  • 4.7.3. By Country

5. Latin America Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 5.1. Introduction
• 5.2. Pricing Analysis
• 5.3. Market Volume Analysis
• 5.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 5.4.1. Brazil
  • 5.4.2. Mexico
  • 5.4.3. Rest of Latin America
• 5.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 5.5.1. Atrial Fibrillation
  • 5.5.2. Sinus Node Dysfunction
  • 5.5.3. Atrioventricular Block
  • 5.5.4. Others
• 5.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 5.6.1. Hospitals
  • 5.6.2. Ambulatory surgical centers
• 5.7. Market Attractiveness Analysis
  • 5.7.1. By Application Type
  • 5.7.2. By End user
  • 5.7.3. By Country

6. Europe Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 6.1. Introduction
• 6.2. Pricing Analysis
• 6.3. Market Volume Analysis
• 6.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 6.4.1. Germany
  • 6.4.2. U.K.
  • 6.4.3. France
  • 6.4.4. Italy
  • 6.4.5. Spain
  • 6.4.6. Rest of Europe
• 6.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 6.5.1. Atrial Fibrillation
  • 6.5.2. Sinus Node Dysfunction
  • 6.5.3. Atrioventricular Block
  • 6.5.4. Others
• 6.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 6.6.1. Hospitals
  • 6.6.2. Ambulatory surgical centers
• 6.7. Market Attractiveness Analysis
  • 6.7.1. By Application Type
  • 6.7.2. By End user
  • 6.7.3. By Country

7. Asia Pacific (APAC) Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 7.1. Introduction
• 7.2. Pricing Analysis
• 7.3. Market Volume Analysis
• 7.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 7.4.1. China
  • 7.4.2. India
  • 7.4.3. Japan
  • 7.4.4. Australia and New Zealand
  • 7.4.5. Rest of APAC
• 7.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 7.5.1. Atrial Fibrillation
  • 7.5.2. Sinus Node Dysfunction
  • 7.5.3. Atrioventricular Block
  • 7.5.4. Others
• 7.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 7.6.1. Hospitals
  • 7.6.2. Ambulatory surgical centers
• 7.7. Market Attractiveness Analysis
  • 7.7.1. By Application Type
  • 7.7.2. By End user
  • 7.7.3. By Country

8. Middle East and Africa (MEA) Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 8.1. Introduction
• 8.2. Pricing Analysis
• 8.3. Market Volume Analysis
• 8.4. Market Size (US$ Mn) Forecast By Country, 2024-2031
  • 8.4.1. GCC Countries
  • 8.4.2. South Africa
  • 8.4.3. Rest of MEA
• 8.5. Market Size (US$ Mn) Forecast By Application Type, 2024-2031
  • 8.5.1. Atrial Fibrillation
  • 8.5.2. Sinus Node Dysfunction
  • 8.5.3. Atrioventricular Block
  • 8.5.4. Others
• 8.6. Market Size (US$ Mn) Forecast By End user, 2024-2031
  • 8.6.1. Hospitals
  • 8.6.2. Ambulatory surgical centers
• 8.7. Market Attractiveness Analysis
  • 8.7.1. By Application Type
  • 8.7.2. By End user
  • 8.7.3. By Country

9. Competition Landscape

• 9.1. Competition Dashboard
• 9.2. Market Share Analysis (2024)
• 9.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
• 9.4. Key Players
  • 9.4.1. Abbott Laboratories
  • 9.4.2. Medtronic Plc

10. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031, By Region

• 10.1. Introduction
  • 10.1.1. Market Share Analysis By Region
  • 10.1.2. Y-o-Y Growth Projections By Region
• 10.2. Market Size Analysis 2024-2031, By Region
  • 10.2.1. North America
  • 10.2.2. Latin America
  • 10.2.3. Europe
  • 10.2.4. Asia Pacific (APAC)
  • 10.2.5. Middle East and Africa (MEA)
• 10.3. Market Attractiveness Analysis By Region

11. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031, By Application Type

• 11.1. Introduction
  • 11.1.1. Market Share Analysis By Application Type
  • 11.1.2. Y-o-Y Growth Projections By Application Type
• 11.2. Market Size Analysis 2024-2031, By Application Type
  • 11.2.1. Atrial Fibrillation
  • 11.2.2. Sinus Node Dysfunction
  • 11.2.3. Atrioventricular Block
  • 11.2.4. Others
• 11.3. Market Attractiveness Analysis By Application Type

12. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031, By End User

• 12.1. Introduction
  • 12.1.1. Market Share Analysis By End User
  • 12.1.2. Y-o-Y Growth Projections By End User
• 12.2. Market Size Analysis 2024-2031, By End User
  • 12.2.1. Hospitals
  • 12.2.2. Ambulatory surgical centers
• 12.3. Market Attractiveness Analysis By End User

13. Global Leadless Pacing System Market Analysis 2019-2023 and Forecast 2024-2031

• 13.1. Market Size and Y-o-Y Growth
• 13.2. Market Volume Analysis
• 13.3. Absolute $ Opportunity

14. Assumptions and Acronyms Used

15. Research Methodology